查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1387365

临床营养市场报告：2030 年趋势、预测与竞争分析

Clinical Nutrition Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

临床营养的趋势和预测

预计到 2030 年，全球临床营养市场将达到 1,109 亿美元，2024 年至 2030 年复合年增长率为 8.1%。该市场的主要驱动力是代谢疾病盛行率的上升以及新兴国家中阶不断壮大的势头。全球临床营养市场前景广阔，癌症、神经、胃肠、代谢疾病市场蕴藏商机。

临床营养市场洞察

Lucintel 预计，由于营养不良的患者数量不断增加，口服药物在预测期内仍将是最大的市场区隔。

在这个市场中，由于慢性病患者数量迅速增加，癌症可能仍然是最大的细分市场。

由于在发展医疗基础设施方面进行了大量投资，预计亚太地区将在预测期内实现最高成长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球临床营养市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球临床营养市场趋势（2018-2023）与预测（2024-2030）
  • 按给药途径分類的全球临床营养市场
    • 口服
    • 肠内的
    • 胃肠外的
  • 按应用分類的全球临床营养市场
    • 癌症
    • 神经系统疾病
    • 胃肠道疾病
    • 代谢紊乱
    • 其他的
  • 按最终用途分類的全球临床营养市场
    • 儿童
    • 成人
    • 老年人
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球临床营养市场（按地区）
  • 北美临床营养市场
  • 欧洲临床营养市场
  • 亚太临床营养市场
  • 其他地区临床营养市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按给药途径分類的全球临床营养市场成长机会
    • 全球临床营养市场成长机会（按应用）
    • 按最终用途分類的全球临床营养市场成长机会
    • 按地区分類的全球临床营养市场成长机会
  • 全球临床营养市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球临床营养市场的能力
    • 全球临床营养市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Fresenius
  • KGAA
  • Baxter International
  • Abbott Laboratories
  • Lonza
  • B. Braun Melsungen
  • Danone Nutricia
  • Perrigo Company
  • Nestle
  • Hero Nutritionals
简介目录

Clinical Nutrition Trends and Forecast

The future of the global clinical nutrition market looks promising with opportunities in the cancer, neurological diseases, gastrointestinal disorders, and metabolic disorders markets. The global clinical nutrition market is expected to reach an estimated $110.9 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are escalating prevalence of metabolic disorders and expansion of the middle class in emerging economies is gaining momentum.

A more than 150-page report is developed to help in your business decisions.

Clinical Nutrition by Segment

The study includes a forecast for the global clinical nutrition by route of administration, application, end use, and region.

Clinical Nutrition Market by Route Of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Enteral
  • Parenteral

Clinical Nutrition Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders
  • Others

Clinical Nutrition Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pediatric
  • Adults
  • Geriatric
  • Others

Clinical Nutrition Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Nutrition Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical nutrition companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical nutrition companies profiled in this report include-

  • Fresenius
  • KGAA
  • Baxter International
  • Abbott Laboratories
  • Lonza
  • B. Braun Melsungen
  • Danone Nutricia
  • Perrigo Company
  • Nestle
  • Hero Nutritionals

Clinical Nutrition Market Insights

Lucintel forecasts that oral will remain the largest segment over the forecast period due to growing number of patients are experiencing malnutrition.

Within this market, cancer will remain the largest segment due to surge in individuals with chronic ailments is evident.

APAC is expected to witness highest growth over the forecast period due to significant investments are being made in the development of healthcare infrastructure in the region.

Features of the Global Clinical Nutrition Market

Market Size Estimates: Clinical nutrition market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical nutrition market size by route of administration, application, end use, and region in terms of value ($B).

Regional Analysis: Clinical nutrition market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, applications, end uses, and regions for the clinical nutrition market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical nutrition market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the clinical nutrition market size?

Answer: The global clinical nutrition market is expected to reach an estimated $110.9 billion by 2030.

Q2. What is the growth forecast for clinical nutrition market?

Answer: The global clinical nutrition market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the clinical nutrition market?

Answer: The major drivers for this market are escalating prevalence of metabolic disorders and expansion of the middle class in emerging economies is gaining momentum.

Q4. What are the major segments for clinical nutrition market?

Answer: The future of the clinical nutrition market looks promising with opportunities in the cancer, neurological diseases, gastrointestinal disorders, and metabolic disorders markets.

Q5. Who are the key clinical nutrition market companies?

Answer: Some of the key clinical nutrition companies are as follows:

  • Fresenius
  • KGAA
  • Baxter International
  • Abbott Laboratories
  • Lonza
  • B. Braun Melsungen
  • Danone Nutricia
  • Perrigo Company
  • Nestle
  • Hero Nutritionals

Q6. Which clinical nutrition market segment will be the largest in future?

Answer: Lucintel forecasts that oral will remain the largest segment over the forecast period due to growing number of patients are experiencing malnutrition.

Q7. In clinical nutrition market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to significant investments are being made in the development of healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical nutrition market by route of administration (oral, enteral, and parenteral), application (cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others), end use (pediatric, adults, geriatric, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Nutrition Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Nutrition Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Nutrition Market by Route Of Administration
    • 3.3.1: Oral
    • 3.3.2: Enteral
    • 3.3.3: Parenteral
  • 3.4: Global Clinical Nutrition Market by Application
    • 3.4.1: Cancer
    • 3.4.2: Neurological Diseases
    • 3.4.3: Gastrointestinal Disorders
    • 3.4.4: Metabolic Disorders
    • 3.4.5: Others
  • 3.5: Global Clinical Nutrition Market by End Use
    • 3.5.1: Pediatric
    • 3.5.2: Adults
    • 3.5.3: Geriatric
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Nutrition Market by Region
  • 4.2: North American Clinical Nutrition Market
    • 4.2.2: North American Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others
  • 4.3: European Clinical Nutrition Market
    • 4.3.1: European Clinical Nutrition Market by Route Of Administration: Oral, Enteral, and Parenteral
    • 4.3.2: European Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others
  • 4.4: APAC Clinical Nutrition Market
    • 4.4.1: APAC Clinical Nutrition Market by Route Of Administration: Oral, Enteral, and Parenteral
    • 4.4.2: APAC Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others
  • 4.5: ROW Clinical Nutrition Market
    • 4.5.1: ROW Clinical Nutrition Market by Route Of Administration: Oral, Enteral, and Parenteral
    • 4.5.2: ROW Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Nutrition Market by Route Of Administration
    • 6.1.2: Growth Opportunities for the Global Clinical Nutrition Market by Application
    • 6.1.3: Growth Opportunities for the Global Clinical Nutrition Market by End Use
    • 6.1.4: Growth Opportunities for the Global Clinical Nutrition Market by Region
  • 6.2: Emerging Trends in the Global Clinical Nutrition Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Nutrition Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Nutrition Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Fresenius
  • 7.2: KGAA
  • 7.3: Baxter International
  • 7.4: Abbott Laboratories
  • 7.5: Lonza
  • 7.6: B. Braun Melsungen
  • 7.7: Danone Nutricia
  • 7.8: Perrigo Company
  • 7.9: Nestle
  • 7.10: Hero Nutritionals